Expand TNYA Menu
TNYA MENU

TNYA Latest Press Releases

-- June 29, 2026 --

Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer Globe Newswire 8:30 AM

-- June 3, 2026 --

Tenaya Therapeutics Announces Interim Data from MyPEAK -1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms Globe Newswire 7:00 AM

-- June 2, 2026 --

Tenaya Therapeutics to Announce New Interim Data from MyPEAK -1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated HCM on Wednesday, June 3, 2026 Globe Newswire 4:30 PM

-- May 29, 2026 --

Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026 Globe Newswire 8:00 AM

-- May 15, 2026 --

Positive Interim Data from Cohorts 1 and 2 of Tenaya's RIDGE -1 Phase 1b/2 Clinical Trial of TN-401 Demonstrated Consistent Reductions in Arrhythmia Burden for Adults with PKP2-associated ARVC Globe Newswire 6:01 AM

-- May 6, 2026 --

Tenaya Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- April 27, 2026 --

Tenaya Therapeutics Announces Late-Breaking Oral Presentation of New Clinical Data from RIDGE -1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy in Adults with PKP2-Associated ARVC at ASGCT 2026 Globe Newswire 8:30 AM

-- March 11, 2026 --

Tenaya Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- March 9, 2026 --

Tenaya Therapeutics Presents Preclinical Data at MDA 2026 Highlighting TN-301's Potential to Correct Skeletal and Cardiac Muscle Decline in Duchenne Muscular Dystrophy Globe Newswire 8:30 AM

-- March 5, 2026 --

Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics Globe Newswire 8:30 AM

-- March 2, 2026 --

Tenaya Therapeutics to Participate in the Leerink Partners Global Healthcare Conference 2026 Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes